Coastal Infusion Administers Pombility™
| J-Code | J1203 |
|---|---|
| Manufacturer | Amicus Therapeutics |
| First Approved | 09/08/2023 |
Coastal Infusion can administer your Pombility prescription at any of our south Florida locations.
Pombility (alglucosidase alfa) is a hydrolytic lysosomal glycogen-specific enzyme indicated for patients with a rare genetic order called Pompe disease, an inherited disorder in which patients have breathing difficulties and muscle weakness.
Pombility is a form of enzyme replacement therapy that replaces the missing enzyme alpha-glucosidase, which is needed to break down a complex sugar called glycogen. By providing the missing enzyme, Pombility helps to reduce the buildup of glycogen in the body’s cells, particularly in the muscles, where Pompe disease can cause weakness and damage.
What It Treats
Pombility is used to treat Pompe Disease.
Prescribed By
Pombility is most often prescribed by Neurologists, Nephrologists, and Metabolic Specialists.
How it’s Administered
Pombility is administered by intravenous infusion. Pombility infusions take about four hours.
Frequency
Pombility is generally administered every two weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies